Status:
UNKNOWN
Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19
Lead Sponsor:
Genesis Foundation
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
Abstract The objective of this study is to review, through prospective case research, the efficacy of oral chlorine dioxide in the treatment of patients with COVID infection 19. The research will be c...
Detailed Description
Test plan overview Project phase Phase II Indication: Complementary treatment of COVID 19 The purpose of the study: Examine the efficacy and tolerance of a chlorine dioxide based preparation Stud...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- \- to. Covid 19 positives b. Some of the characteristic symptoms of covid 19: fever, odynophagia, respiratory distress.
- c. Age between 18 years and 80 years
- Criteria Exclusion:
- to. Covid 19 negatives b. Kidney failure IV / VI. c. Congestive heart failure. d. Patients taking anticoagulants, particularly warfarin sodium
Exclusion
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04343742
Start Date
April 1 2020
End Date
June 1 2020
Last Update
May 27 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Fhsj
Bogota, Cundinamarca, Colombia
2
San Carlos Hospital
Bogota, Cundinamarca, Colombia